Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Malkowicz

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Human Genetics|September 14, 2000
Association of HPC2/ELAC2 genotypes and prostate cancerT R Rebbeck, A H Walker, C Zeigler-Johnson, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Cancer Research|April 5, 2000
Association of SRD5A2 genotype and pathological characteristics of prostate tumorsJ M Jaffe, S B Malkowicz, A H Walker, et al.
JAMA|January 8, 1997
Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantationE Loh, F J Couch, C Hendricksen, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
International Journal of Cancer|March 30, 2000
Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinomaK Ge, F Minhas, J Duhadaway, et al.
Urology|September 11, 2001
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screeningA V D'Amico, R Whittington, S B Malkowicz, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 28, 2015
A heterogeneous algorithm for PDT dose optimization for prostateMartin D Altschuler, Timothy C Zhu, Yida Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Human Genetics|September 14, 2000
Association of HPC2/ELAC2 genotypes and prostate cancerT R Rebbeck, A H Walker, C Zeigler-Johnson, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Cancer Research|April 5, 2000
Association of SRD5A2 genotype and pathological characteristics of prostate tumorsJ M Jaffe, S B Malkowicz, A H Walker, et al.
JAMA|January 8, 1997
Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantationE Loh, F J Couch, C Hendricksen, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
International Journal of Cancer|March 30, 2000
Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinomaK Ge, F Minhas, J Duhadaway, et al.
Urology|September 11, 2001
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screeningA V D'Amico, R Whittington, S B Malkowicz, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 28, 2015
A heterogeneous algorithm for PDT dose optimization for prostateMartin D Altschuler, Timothy C Zhu, Yida Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Pageof 12